Ang, Wee HanDaldini, ElisaJuillerat-Jeanneret, LucienneDyson, Paul J.2007-12-132007-12-132007-12-13200710.1021/ic701474mhttps://infoscience.epfl.ch/handle/20.500.14299/15615WOS:00025034540001111492In order to utilize macromols. for drug targeting and delivery, a strategy to tether organometallic ruthenium-arene drugs to carrier protein mols. was developed. The approach involves the design of a drug fragment capable of conjugating to linker mols. on a modified carrier protein via hydrazone bond formation. The proof-of-concept using recombinant human serum albumin is described.text::journal::journal article::research article